The Science Advisory Board

President Biden launches $50M initiative to improve cancer outcomes in low-income areas

The Biden-Harris administration on Monday awarded $50 million to launch the Persistent Poverty Initiativ...

3D cellular models identify potential drug target for preventing Alzheimer’s

A 3D cellular model has shown that mutations affec...

Gene mutations linked to drug-resistant liver cancer

Certain gene mutations could serve as markers to hel...

Potential treatment for rare autoimmune disorder adapted from CAR-T therapy in study

Evidence from a small-scale clinical trial suggest...

FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy

The U.S. Food and Drug Administration (FDA) on Thursda...

Cancer & Disease Research

Illumina brings whole-genome sequencing to German hospital
April 27, 2022 -- Illumina has signed an agreement with Hannover Medical School in Germany to assess the use of rapid whole-genome sequencing (rWGS) in critically ill children suspected of having a genetic or rare disease. Read More

Advances in gene therapy call for education, patient advocate says
April 26, 2022 -- Durhane Wong-Rieger, board chair of Rare Diseases International, spoke to ScienceBoard.net at the Cell & Gene Meeting on the Med last week in Barcelona, Spain, following a panel on trends and challenges in gene therapy. Read More